Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Capital Employed: 2022-2025

Historic Return on Capital Employed for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to -0.48%.

  • Centessa Pharmaceuticals' Return on Capital Employed fell 15.00% to -0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.48%, marking a year-over-year decrease of 15.00%. This contributed to the annual value of -0.49% for FY2024, which is 2.00% down from last year.
  • Centessa Pharmaceuticals' Return on Capital Employed amounted to -0.48% in Q3 2025, which was down 12.78% from -0.43% recorded in Q2 2025.
  • In the past 5 years, Centessa Pharmaceuticals' Return on Capital Employed ranged from a high of -0.34% in Q3 2024 and a low of -0.53% during Q1 2023.
  • Its 3-year average for Return on Capital Employed is -0.46%, with a median of -0.48% in 2025.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Return on Capital Employed grew by 17bps in 2024, and later fell by 15bps in 2025.
  • Over the past 4 years, Centessa Pharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.50% in 2022, then fell by 2bps to -0.52% in 2023, then grew by 14bps to -0.38% in 2024, then dropped by 15bps to -0.48% in 2025.
  • Its Return on Capital Employed was -0.48% in Q3 2025, compared to -0.43% in Q2 2025 and -0.37% in Q1 2025.